BIOMAT Database Logo BIOMAT Database Logo

Macrocyclic inhibitors of the bacterial cell wall biosynthesis enzyme MurD. 2003

James R Horton, and Julieanne M Bostock, and Ian Chopra, and Lars Hesse, and Simon E V Phillips, and David J Adams, and A Peter Johnson, and Colin W G Fishwick
Departments of Chemistry, University of Leeds, Leeds LS2 9JT, UK.

Computer-based molecular design has been used to produce a series of new macrocyclic systems targeted against the bacterial cell wall biosynthetic enzyme MurD. Following their preparation, which involved a novel metathesis-based cyclisation as the key step, these systems were found to show good inhibition when assayed against the MurD enzyme.

UI MeSH Term Description Entries
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D010453 Peptide Synthases Ligases that catalyze the joining of adjacent AMINO ACIDS by the formation of carbon-nitrogen bonds between their carboxylic acid groups and amine groups. Peptide Synthetases,Acid-Amino-Acid Ligases,Acid Amino Acid Ligases,Ligases, Acid-Amino-Acid,Synthases, Peptide,Synthetases, Peptide
D002473 Cell Wall The outermost layer of a cell in most PLANTS; BACTERIA; FUNGI; and ALGAE. The cell wall is usually a rigid structure that lies external to the CELL MEMBRANE, and provides a protective barrier against physical or chemical agents. Cell Walls,Wall, Cell,Walls, Cell
D004791 Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzyme Inhibitor,Inhibitor, Enzyme,Inhibitors, Enzyme
D004926 Escherichia coli A species of gram-negative, facultatively anaerobic, rod-shaped bacteria (GRAM-NEGATIVE FACULTATIVELY ANAEROBIC RODS) commonly found in the lower part of the intestine of warm-blooded animals. It is usually nonpathogenic, but some strains are known to produce DIARRHEA and pyogenic infections. Pathogenic strains (virotypes) are classified by their specific pathogenic mechanisms such as toxins (ENTEROTOXIGENIC ESCHERICHIA COLI), etc. Alkalescens-Dispar Group,Bacillus coli,Bacterium coli,Bacterium coli commune,Diffusely Adherent Escherichia coli,E coli,EAggEC,Enteroaggregative Escherichia coli,Enterococcus coli,Diffusely Adherent E. coli,Enteroaggregative E. coli,Enteroinvasive E. coli,Enteroinvasive Escherichia coli
D006571 Heterocyclic Compounds Cyclic compounds that include atoms other than carbon in their ring structure. Heterocyclic Compound,Compound, Heterocyclic,Compounds, Heterocyclic
D001665 Binding Sites The parts of a macromolecule that directly participate in its specific combination with another molecule. Combining Site,Binding Site,Combining Sites,Site, Binding,Site, Combining,Sites, Binding,Sites, Combining
D013237 Stereoisomerism The phenomenon whereby compounds whose molecules have the same number and kind of atoms and the same atomic arrangement, but differ in their spatial relationships. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed) Molecular Stereochemistry,Stereoisomers,Stereochemistry, Molecular,Stereoisomer
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D015195 Drug Design The molecular designing of drugs for specific purposes (such as DNA-binding, enzyme inhibition, anti-cancer efficacy, etc.) based on knowledge of molecular properties such as activity of functional groups, molecular geometry, and electronic structure, and also on information cataloged on analogous molecules. Drug design is generally computer-assisted molecular modeling and does not include PHARMACOKINETICS, dosage analysis, or drug administration analysis. Computer-Aided Drug Design,Computerized Drug Design,Drug Modeling,Pharmaceutical Design,Computer Aided Drug Design,Computer-Aided Drug Designs,Computerized Drug Designs,Design, Pharmaceutical,Drug Design, Computer-Aided,Drug Design, Computerized,Drug Designs,Drug Modelings,Pharmaceutical Designs

Related Publications

James R Horton, and Julieanne M Bostock, and Ian Chopra, and Lars Hesse, and Simon E V Phillips, and David J Adams, and A Peter Johnson, and Colin W G Fishwick
Inhibitors of the bacterial cell wall biosynthesis enzyme MurD.
July 1998, Bioorganic & medicinal chemistry letters,
James R Horton, and Julieanne M Bostock, and Ian Chopra, and Lars Hesse, and Simon E V Phillips, and David J Adams, and A Peter Johnson, and Colin W G Fishwick
Peptide inhibitors of MurD and MurE, essential enzymes of bacterial cell wall biosynthesis.
June 2008, Journal of basic microbiology,
James R Horton, and Julieanne M Bostock, and Ian Chopra, and Lars Hesse, and Simon E V Phillips, and David J Adams, and A Peter Johnson, and Colin W G Fishwick
Inhibitors of the bacterial cell wall biosynthesis enzyme MurC.
June 2001, Bioorganic & medicinal chemistry letters,
James R Horton, and Julieanne M Bostock, and Ian Chopra, and Lars Hesse, and Simon E V Phillips, and David J Adams, and A Peter Johnson, and Colin W G Fishwick
Selection of peptide inhibitors against the Pseudomonas aeruginosa MurD cell wall enzyme.
July 2006, Peptides,
James R Horton, and Julieanne M Bostock, and Ian Chopra, and Lars Hesse, and Simon E V Phillips, and David J Adams, and A Peter Johnson, and Colin W G Fishwick
Pulvinones as bacterial cell wall biosynthesis inhibitors.
January 2006, Bioorganic & medicinal chemistry letters,
James R Horton, and Julieanne M Bostock, and Ian Chopra, and Lars Hesse, and Simon E V Phillips, and David J Adams, and A Peter Johnson, and Colin W G Fishwick
[Antibiotics--inhibitors in biosynthesis of the bacterial cell-wall].
January 1971, Postepy biochemii,
James R Horton, and Julieanne M Bostock, and Ian Chopra, and Lars Hesse, and Simon E V Phillips, and David J Adams, and A Peter Johnson, and Colin W G Fishwick
Anthranilic Acid Inhibitors of Undecaprenyl Pyrophosphate Synthase (UppS), an Essential Enzyme for Bacterial Cell Wall Biosynthesis.
January 2018, Frontiers in microbiology,
James R Horton, and Julieanne M Bostock, and Ian Chopra, and Lars Hesse, and Simon E V Phillips, and David J Adams, and A Peter Johnson, and Colin W G Fishwick
Bacterial cell wall biosynthesis.
January 1972, Ciba Foundation symposium,
James R Horton, and Julieanne M Bostock, and Ian Chopra, and Lars Hesse, and Simon E V Phillips, and David J Adams, and A Peter Johnson, and Colin W G Fishwick
An enzyme-substrate complex involved in bacterial cell wall biosynthesis.
August 1995, Nature structural biology,
James R Horton, and Julieanne M Bostock, and Ian Chopra, and Lars Hesse, and Simon E V Phillips, and David J Adams, and A Peter Johnson, and Colin W G Fishwick
[Biosynthesis of the bacterial cell wall].
December 1967, Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme,
Copied contents to your clipboard!